🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study will enroll individuals who have: * Completed primary series of...
Status
Completed
Location
University of California, San Diego
Start Date
2021-12-06
Trial ID
NCT05077254
Aim: To investigate if a subcutaneous (s.c.) booster dose of 90 µg of the n...
Status
Unknown
Location
University Medical Center Groningen
Start Date
2022-04-21
Trial ID
NCT05124483
Treatments Being Tested
The purpose of this study was to understand whether participants could moun...
Status
Completed
Location
Novartis Investigative Site
Start Date
2021-04-19
Trial ID
NCT04792567
Treatments Being Tested
AICOVI (Adaptive Immune Response to COVID-19 Vaccination) is a prospective ...
Status
Unknown
Location
University Medicine Greifswald
Start Date
2021-01-06
Trial ID
NCT04826770
This clinical trial will be a blinded, randomised study to determine the sa...
Status
Withdrawn
Location
Royal Children's Hospital, Murdoch Children's Research Institute
Start Date
2022-05-02
Trial ID
NCT05543356
This is a randomised controlled, adaptive, multicentre Phase II protocol ev...
Status
Completed
Location
University Hospital Cologne
Start Date
2021-11-08
Trial ID
NCT05160766
Treatments Being Tested
Antibodies are an important part of the body's defense against infection. I...
Status
Completed
Location
Johns Hopkins Hospital
Start Date
2021-08-10
Trial ID
NCT04969263
Treatments Being Tested
The primary objectives of this study are: In infants of women exposed to S...
Status
Completed
Location
Carelon Research
Start Date
2023-03-01
Trial ID
NCT06369272
The main goal of this study is to characterize presentation, clinical cours...
Status
Active Not Recruiting
Location
Veradigm
Start Date
2022-04-30
Trial ID
NCT06189053
Under protocol versions 1.01-1.06: The five recently emerged SARS-CoV2 vari...
Status
Completed
Location
Sheba Medical Center
Start Date
2022-09-05
Trial ID
NCT05383560
Treatments Being Tested